Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-891-0 | CAS number: 89-25-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Irritation/Corrosion
The registered substance 1-phenyl-3-methyl-5-pyrazolone is classified as non-irritant substance according REACh and CLP regulation based on In vivo skin irritation study results.
Eye irritation
The registered substance 1-phenyl-3-methyl-5-pyrazolone is classified as non-irritant substance according REACh and CLP regulation based on In vivo eye irritation study results.
Key value for chemical safety assessment
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Eye irritation :
The key study (OECD Guideline 405, 100mg of pure substance, GLP, Klimisch 2) is an Eye Irritation Test on New Zelands rabbits. Three rabbits were exposed to 100g of pure 1-phenyl-3-methyl-5-pyrazolone through eye instillation into conjunctival sac on the left eye. The treatment period was 24 hours, no rinsing was made. Ocular reactions were observed and scored as cornea ulceration, conjunctivae redness, iris hemorrahge or discharge compared to the untreated right eye at different time points : 1, 24, 48 and 72 hours post-treatment. Treatment with registered item did not induce ocular reactions.
Two others studies were availables to determine the potential eye irritation of the substance. Nevertheless, these studies reports datas from Bovine Corneal Opacity and Permability Test (BCOP) and Hen's Egg Test ChorioAllantoïc Membrane (HET CAM), which were not sufficient to etablish a classification below the category 1A as irritant according REACh and CLP regulations.
Irritation/Corrosion
Clouzeau, 1992 :
The test available (OECD Guideline 404, GLP, Klimish 2) is a in vivo skin irritation test in which rabbits were exposed to 0.5ml of 1% of the substance diluted. However, this concentration of 1% is not suitable to assess irritation/corrosion properties of the pure substance, as recommended in REACh regulation. The results of the study showed mild transcient irritation.
Leist, 1980:
The hair in the dorsal region of the body of 6 rabbits was remoced with an electric clipper over an area of about 3x 6 cm. One half of the clipped skin was in addition scarified with a scarificator. Each animal was treated with 500 mg of 1-Phenyl-3-methyl-5-pyrazolon pasted with 0.35 ml physiologic saline solution. The substance was evenly distributed over the whole surface of 2.3 x 2.5 cm cellulose patch on a piece of surgical plaster (Hansamed(R)). The plaster was fixed to the prepared skin area and covered with a indifferent, impermeable polyethylene film (6-8cm wide). Finally the animals body was fixed with an elastic bandage. The exposure period was 4 hours. A first examination took place immediately after removal of the patches. Further examination tool place after 48 and 72 hours post application. After application of the substance (pasty form) an irritation index score of 1.5 was determined. Due to classification according to the FDA guideline mentionned in the report, the substance was therefore to be described as slighty irritant. under CLP regulation, the obtained score of 1.5 did not led to a EU-CLP classification. Hence, the test article was not classified for Skin Irritation.
The identity of the test substance was not sufficiently documented. Only a summary test report was available, there was no raw data. However, the study was conducted under FDA test protocols. Appropriate dose level was used. The scoring system deviated slighty from the current OECD protocol. Control analysis was performed. Restriction for reliability was due to the age of the study (1980). However, this study was considered as relevant.
Sire, 2004 : in a skin sensitisation study (LLNA -Klimisch 1) where the substance was applied for 6 day up to 25%, on the mouse ear, no irritant effects were observed and confirm the non irritant properties of the substance.
Justification for classification or non-classification
Eye irritation
Based on the result of the key study for skin irritation, the registered substance 1-phenyl-3-mehtyl-5-pyrazolone is classified as non-irritant for eyes according CLP and REACh regulation.
Irritation/Corrosion
Based on the results of two availables studies on skin irritation, and data available for skin sensitisation and according to the CLP criteria, the test article 1 -phenyl-3 -methyl-5-pyrazolone was not classififed for skin irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.